Literature DB >> 22981382

Molecular insight in the multifunctional activities of Withaferin A.

Wim Vanden Berghe1, Linde Sabbe, Mary Kaileh, Guy Haegeman, Karen Heyninck.   

Abstract

Herbal medicine which involves the use of plants for their medicinal value, dates as far back as the origin of mankind and demonstrates an array of applications including cardiovascular protection and anti-cancer activities, via antioxidant, anti-inflammatory and metabolic activities. Even today the popularity of medicinal herbs is still growing like in traditional medicines such as the Indian medicine, Ayurveda. One of the Ayurvedic medicinal plants is Withania somnifera Dunal, of which the important constituents are the withanolides. Among them, Withaferin A is one of the most bioactive compounds, exerting anti-inflammatory, pro-apoptotic but also anti-invasive and anti-angiogenic effects. In the context of modern pharmacology, a better insight in the underlying mechanism of the broad range of bioactivities exerted by Withaferin A is compulsory. Therefore, a lot of effort was made to explore the intracellular effects of Withaferin A and to characterize its target proteins. This review provides a decisive insight on the molecular basis of the health-promoting potential of Withaferin A.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22981382     DOI: 10.1016/j.bcp.2012.08.027

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  76 in total

1.  Effect of Withania somnifera root extract on spontaneous estrogen receptor-negative mammary cancer in MMTV/Neu mice.

Authors:  Kamel F Khazal; Donald L Hill; Clinton J Grubbs
Journal:  Anticancer Res       Date:  2014-11       Impact factor: 2.480

Review 2.  Withania somnifera: From prevention to treatment of cancer.

Authors:  Dushani L Palliyaguru; Shivendra V Singh; Thomas W Kensler
Journal:  Mol Nutr Food Res       Date:  2016-01-29       Impact factor: 5.914

3.  Withaferin A Improves Nonalcoholic Steatohepatitis in Mice.

Authors:  Daxesh P Patel; Tingting Yan; Donghwan Kim; Henrique B Dias; Kristopher W Krausz; Shioko Kimura; Frank J Gonzalez
Journal:  J Pharmacol Exp Ther       Date:  2019-08-16       Impact factor: 4.030

4.  An image-based small-molecule screen identifies vimentin as a pharmacologically relevant target of simvastatin in cancer cells.

Authors:  Kathryn P Trogden; Rachel A Battaglia; Parijat Kabiraj; Victoria J Madden; Harald Herrmann; Natasha T Snider
Journal:  FASEB J       Date:  2018-01-18       Impact factor: 5.191

5.  Withaferin A Analogs That Target the AAA+ Chaperone p97.

Authors:  Shasha Tao; Joseph Tillotson; E M Kithsiri Wijeratne; Ya-Ming Xu; MinJin Kang; Tongde Wu; Eric C Lau; Celestina Mesa; Damian J Mason; Robert V Brown; James J La Clair; A A Leslie Gunatilaka; Donna D Zhang; Eli Chapman
Journal:  ACS Chem Biol       Date:  2015-06-03       Impact factor: 5.100

6.  Role of mitogen-activated protein kinases and Mcl-1 in apoptosis induction by withaferin A in human breast cancer cells.

Authors:  Eun-Ryeong Hahm; Joomin Lee; Shivendra V Singh
Journal:  Mol Carcinog       Date:  2013-09-09       Impact factor: 4.784

7.  Alleviation of instant blood-mediated inflammatory reaction in autologous conditions through treatment of human islets with NF-κB inhibitors.

Authors:  Mazhar A Kanak; Morihito Takita; Takeshi Itoh; Jeffrey A SoRelle; Shyam Murali; Faisal Kunnathodi; Rauf Shahbazov; Michael C Lawrence; Marlon F Levy; Bashoo Naziruddin
Journal:  Transplantation       Date:  2014-09-15       Impact factor: 4.939

8.  Covalent modification of the NF-κB essential modulator (NEMO) by a chemical compound can regulate its ubiquitin binding properties in vitro.

Authors:  Christopher Hooper; Shawn S Jackson; Emma E Coughlin; Joshua J Coon; Shigeki Miyamoto
Journal:  J Biol Chem       Date:  2014-10-08       Impact factor: 5.157

9.  A small molecule inhibitor of NFκB blocks ER stress and the NLRP3 inflammasome and prevents progression of pancreatitis.

Authors:  Mazhar A Kanak; Rauf Shahbazov; Gumpei Yoshimatsu; Marlon F Levy; Michael C Lawrence; Bashoo Naziruddin
Journal:  J Gastroenterol       Date:  2016-07-14       Impact factor: 7.527

10.  Withaferin A inhibits pro-inflammatory cytokine-induced damage to islets in culture and following transplantation.

Authors:  J A SoRelle; T Itoh; H Peng; M A Kanak; K Sugimoto; S Matsumoto; M F Levy; M C Lawrence; B Naziruddin
Journal:  Diabetologia       Date:  2013-01-15       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.